| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.057 | 0.2 |